Drugs News and Research

RSS

Malvern Panalytical launches Zetasizer Core – an industry first in biologics plate-based stability screening

Malvern Panalytical's Zetasizer Core integrates DLS, SLS, and DSF in one platform, streamlining biologics discovery with unmatched efficiency and precision.

From Malvern Panalytical 15 Sep 2026

Wearable electroceutical platform enables remote wireless pain management

A "wearable electroceutical" has been developed that could reduce the need to visit a hospital or rely on painkillers every time pain occurs.

15 Sep 2026

Final results from PAPILLON trial confirm long-term survival in a subset of lung cancer

Final results from the landmark PAPILLON trial, which changed the standard of care for a difficult-to-treat rare form of lung cancer, confirm that amivantamab, when added to chemotherapy, provides durable clinical benefit and the longest median overall survival reported to date for people with the disease.

15 Sep 2026

Adjuvant osimertinib delivers long-term survival benefit in EGFR-mutated NSCLC

An exploratory eight-year landmark update from the Phase III ADAURA trial showed that adjuvant osimertinib continued to provide a long-term overall survival benefit for patients with completely resected, EGFR-mutated stage IB-IIIA non-small cell lung cancer (NSCLC).

15 Sep 2026

A study of more than 21,000 adults found an unusual link between psilocybin and diet

Using data from more than 21,800 adults in two UK birth cohorts, researchers found that lifetime psilocybin and LSD use was associated with stronger pro-environmental attitudes and a greater likelihood of following a vegetarian diet, with psilocybin showing the clearer dietary pattern. Mediation analyses suggested that environmental attitudes statistically accounted for the psilocybin-vegetarianism association and part of the association with lower red meat consumption, but the observational design cannot establish causation.

15 Sep 2026

Video game offers new insights into autistic perception

People with autism often come at life from a different angle-seeing details others miss, focusing on patterns rather than faces, experiencing heightened or dimmed physical sensations.

11 Sep 2026

Targeted nanoparticles strengthen anti-cancer immune responses in tumors

Adelaide University researchers have developed a new way of using mRNA technology to reprogram tumor-supporting immune cells and strengthen the body's anti-cancer immune response.

11 Sep 2026

Nanoparticle platform reliably detects true cases of antibiotic allergy

A multidisciplinary scientific team at the University of Malaga has developed a new technology based on magnetic nanoparticles that enables precise, rapid and reliable diagnosis of allergy to beta-lactam antibiotics, including amoxicillin and other penicillins.

11 Sep 2026

Risk factors for cardiovascular-kidney-metabolic disease can be identified in young children

Risk factors for cardiovascular-kidney-metabolic disease, a health condition made up of heart disease, kidney disease, diabetes, and obesity, can be identified in children as young as 8, UTHealth Houston researchers discovered.

11 Sep 2026

Early treatment significantly reduces joint damage in rheumatoid arthritis

Early and consistently managed treatment can have a decisive impact on the course of rheumatoid arthritis and prevent permanent joint damage.

11 Sep 2026

Cancer treatments alter the landscape of genetic mutations in healthy body tissues

Cancer treatments, including chemotherapy and radiotherapy, give a growth advantage to cells with particular genetic changes in healthy tissue, new research finds.

11 Sep 2026

Proteomic signatures reveal early signs of cardiovascular-kidney-metabolic disease in children

Researchers at Vanderbilt Health, UTHealth Houston and the University of North Carolina at Chapel Hill have identified early signs of cardiovascular-kidney-metabolic disease (CKMD) in children as young as 8 years old that potentially can be reversed with a new class of weight loss drugs used widely by adults

11 Sep 2026

Common medications trigger potentially harmful prescribing cascades in older adults

A new Ontario-wide study reveals that common medications, from statins to iron supplements, are quietly setting off prescribing cascades that leave older adults unknowingly taking drugs to treat side effects of other drugs.

10 Sep 2026

Childhood chemotherapy leaves lasting DNA damage in healthy cells

Chemotherapy, which saves the lives of many children with cancer, causes previously unknown DNA alterations in the liver and leaves genetic footprints in other healthy cells as well.

10 Sep 2026

Year-round sun protection helps prevent skin cancer and aging

Sun safety is always in season. It's important to protect your skin from sun damage throughout the year, no matter what the weather.

10 Sep 2026

Study reveals hidden DNA damage from childhood chemotherapy

The amount of DNA damage caused by certain chemotherapies used to effectively treat childhood cancer has been revealed, along with a hidden impact on the liver, paving the way for future research into new ways to mitigate these impacts.

10 Sep 2026

Biolife granted U.S. patent for novel effervescent oral peptide delivery technology

BioLife today announced that the United States Patent and Trademark Office has granted U.S. Patent 12,667,605 B2 for its novel effervescent oral peptide delivery technology, designed to support current and future peptide therapeutics for obesity, diabetes and metabolic disease.

10 Sep 2026

Shortages of crucial cancer medications continue to impact US healthcare

Today, the National Comprehensive Cancer Network® (NCCN®)-an alliance of leading cancer centers-published updated data on the current impact of generic cancer medication shortages in the United States.

10 Sep 2026

Review highlights solute carriers as targets for central nervous system disorders

Solute carriers (SLCs) are specialized transport proteins that control the movement of nutrients, ions and neurotransmitters across cell membranes and are essential for brain metabolism and neuronal communication.

10 Sep 2026

Symptomless liver condition linked to heart and kidney disease

A common liver condition thought to be harmless could be dramatically increasing the risk of heart disease, kidney failure and premature death, according to a new review led by University of Manchester and Northern Care Alliance NHS Foundation Trust researchers.

10 Sep 2026

Drugs News and Research

Malvern Panalytical launches Zetasizer Core – an industry first in biologics plate-based stability screening

Wearable electroceutical platform enables remote wireless pain management

Final results from PAPILLON trial confirm long-term survival in a subset of lung cancer

Adjuvant osimertinib delivers long-term survival benefit in EGFR-mutated NSCLC

A study of more than 21,000 adults found an unusual link between psilocybin and diet

Video game offers new insights into autistic perception

Targeted nanoparticles strengthen anti-cancer immune responses in tumors

Nanoparticle platform reliably detects true cases of antibiotic allergy

Risk factors for cardiovascular-kidney-metabolic disease can be identified in young children

Early treatment significantly reduces joint damage in rheumatoid arthritis

Cancer treatments alter the landscape of genetic mutations in healthy body tissues

Proteomic signatures reveal early signs of cardiovascular-kidney-metabolic disease in children

Common medications trigger potentially harmful prescribing cascades in older adults

Childhood chemotherapy leaves lasting DNA damage in healthy cells

Year-round sun protection helps prevent skin cancer and aging

Study reveals hidden DNA damage from childhood chemotherapy

Biolife granted U.S. patent for novel effervescent oral peptide delivery technology

Shortages of crucial cancer medications continue to impact US healthcare

Review highlights solute carriers as targets for central nervous system disorders

Symptomless liver condition linked to heart and kidney disease

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News